Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RKIP inhibits the malignant phenotypes of gastric cancer cells.

Neoplasma - 1 Jan 2013

Zhang X M, Gu H, Yan L, Zhang G Y

Abstract excerpt

Raf kinase inhibitor protein (RKIP) is first identified as an interacting partner of Raf-1. RKIP expression is low or absent in several established cell lines derived from metastatic breast cancer, prostate cancer and melanoma cells. However, the functional role of RKIP in gastric cancer remains unclear. In this study, we employed human gastric cancer cell line SGC7901 as a model to reconstitute RKIP expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cell Line, Tumor
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Neoplasm Invasiveness

Share to Stomach Neoplasms

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 23259789
DOI: 10.4149/neo_2013_026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RKIP inhibits the malignant phenotypes of gastric cancer cells.PMID 23259789Read ↗

Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysisSemantic proximity Read ↗

Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancerSemantic proximity Read ↗

Survey of Raf Kinase Inhibitor Protein (RKIP) in Multiple Cancer TypesSemantic proximity Read ↗

The biological complexity of RKIP signaling in human cancersSemantic proximity Read ↗

Raf Kinase Inhibitory Protein (RKIP) as a Metastasis Suppressor: Regulation of Signaling Networks in CancerSemantic proximity Read ↗

Correlation among RKIP expression, NF-κB p65 levels, and T-lymphocyte subsets in gastric cardia adenocarcinoma.Semantic proximity Read ↗

Raf Kinase Inhibitor Protein Expression in a Survival Analysis of Colorectal Cancer PatientsSemantic proximity Read ↗

Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implicationsSemantic proximity Read ↗

The Role of RKIP in the Regulation of EMT in the Tumor MicroenvironmentSemantic proximity Read ↗

Loss of RKIP expression during the carcinogenic evolution of endometrial cancer.Semantic proximity Read ↗

Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic targetSemantic proximity Read ↗

KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.